PMID: 8969931Nov 1, 1996Paper

Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line

Endocrine Research
F FalloN Sonino

Abstract

We investigated the effects of taxol, an antimicrotubule agent active in different cancers, on the human NCI-H295 steroid-secreting adrenocortical carcinoma cell line. Cells were incubated for 48, 72 or 96 h with taxol 10(-10)-10(-4) M. Cell viability was evaluated by MTT assay with IC50 calculation. Apoptosis was investigated by measuring DNA fragmentation with ELISA assay after cell exposure to taxol at IC50 for 24 h. For secretion studies, aldosterone, cortisol, testosterone and dehydroepiandrosterone-sulphate (DHEA-S) were measured by RIA in the conditioned medium after 96 h exposure to taxol 10(-10)-10(-6) M, and expressed as percentage of steroid production by control cells. By MTT, taxol induced a dose-dependent inhibition of cell proliferation, with ICs50 at 72-96 h corresponding to blood levels achieved in vivo in patients with other types of cancer. Nuclear fragmentation, morphologically confirmed at electron microscopy, showed a 4-fold increase after exposure to taxol. With 10(-6) M taxol, aldosterone decreased to 48%, cortisol to 61%, testosterone to 76% and DHEA-S to 89% of steroid production by control cells. Taxol is an effective cytotoxic and antiproliferative agent in a human adrenocortical steroid-secreting ca...Continue Reading

References

Apr 26, 1990·The New England Journal of Medicine·J P LutonP Blondeau
Aug 1, 1990·The Journal of Clinical Endocrinology and Metabolism·R V La RoccaC E Myers
Jan 1, 1980·International Review of Cytology·A H WyllieA R Currie
Apr 1, 1994·Mayo Clinic Proceedings·H J Long
Sep 7, 1994·Journal of the National Cancer Institute·B W Stewart

❮ Previous
Next ❯

Citations

Sep 27, 2001·World Journal of Surgery·H AhlmanS Lindstedt
Jan 1, 2000·Journal of Biomolecular Structure & Dynamics·G BischoffS Hoffmann
Jun 12, 2002·Current Treatment Options in Oncology·R P Boushey, A P Dackiw
Jan 5, 2000·Nucleosides & Nucleotides·G BischoffS Hoffmann
Feb 18, 2014·Endocrine-related Cancer·Constanze HantelFelix Beuschlein
Jan 26, 2005·Endocrine Research·Mary H BassettWilliam E Rainey
Jun 28, 2001·Current Problems in Surgery·J A NortonH N Le
Nov 16, 2004·Molecular and Cellular Endocrinology·William E RaineyBernard P Schimmer
Sep 14, 2000·The Urologic Clinics of North America·L S Liou, R Kay
Mar 25, 2000·Endocrinology and Metabolism Clinics of North America·C A Stratakis, G P Chrousos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.